The Effect of IL-5 and Eotaxin Expression in the Lung on Eosinophil Trafficking and Degranulation and the Induction of Bronchial Hyperreactivity1

The mechanisms regulating the selective migration and degranulation of eosinophils in the asthmatic lung and the subsequent development of airways hyperreactivity (AHR) have not been fully delineated. In this investigation, we have employed a novel transgene model to facilitate the dissection of the contributions of IL-5 and/or eotaxin to eosinophil function in the absence of complex tissue signals derived from the allergic lung. Gene transfer of IL-5 and/or eotaxin to the lungs of naive mice induced a pronounced and selective airways eosinophilia, but did not result in eosinophil degranulation or AHR. Airways eosinophilia occurred independently of the induction of a blood eosinophilia, but was markedly augmented by the coexpression of both cytokines and/or by the transient mobilization of eosinophils from the bone marrow by the administration of i.v. IL-5. However, for eosinophil degranulation and AHR to occur, the inhalation of Ag was required in association with IL-5 and eotaxin expression. Investigations in IL-5-deficient mice linked eosinophilia, and not solely IL-5 and eotaxin, with the induction of AHR. Furthermore, eosinophil degranulation and AHR were dependent on CD4+ T cells. Importantly, this investigation shows that IL-5 regulates eosinophilia within the lung as well as in the circulation and also amplifies eotaxin-induced chemotaxis in the airway compartment. Moreover, the interplay between these cytokines, CD4+ T cells, and factors generated by Ag inhalation provides fundamental signals for eosinophil degranulation and the induction of AHR.

[1]  久田 剛志 α4 integrin-dependent eotaxin induction of bronchial hyper-responsiveness and eosinophil migration in interleukin-5 transgenic mice , 2000 .

[2]  K. Chung,et al.  alpha4 integrin-dependent eotaxin induction of bronchial hyperresponsiveness and eosinophil migration in interleukin-5 transgenic mice. , 1999, American journal of respiratory cell and molecular biology.

[3]  D D Donaldson,et al.  Interleukin-13: central mediator of allergic asthma , 1998 .

[4]  D B Corry,et al.  Requirement for IL-13 independently of IL-4 in experimental asthma. , 1998, Science.

[5]  R. E. Wiley,et al.  GM-CSF transgene expression in the airway allows aerosolized ovalbumin to induce allergic sensitization in mice. , 1998, The Journal of clinical investigation.

[6]  M. Jordana,et al.  Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophilia. , 1998, The Journal of clinical investigation.

[7]  P. Foster,et al.  A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5. , 1998, Journal of immunology.

[8]  D. Friend,et al.  Eotaxin is required for the baseline level of tissue eosinophils. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[9]  S. Rankin,et al.  Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. , 1998, Blood.

[10]  J. Gutiérrez-Ramos,et al.  Eotaxin modulates myelopoiesis and mast cell development from embryonic hematopoietic progenitors. , 1998, Blood.

[11]  A. Fryer,et al.  Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. , 1997, The Journal of clinical investigation.

[12]  S. Rankin,et al.  Kinetics of Eotaxin Generation and Its Relationship to Eosinophil Accumulation in Allergic Airways Disease: Analysis in a Guinea Pig Model In Vivo , 1997, The Journal of experimental medicine.

[13]  E. Gelfand,et al.  Interleukin-5 Expression in the Lung Epithelium of Transgenic Mice Leads to Pulmonary Changes Pathognomonic of Asthma , 1997, The Journal of experimental medicine.

[14]  P. Foster,et al.  Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. , 1997, The Journal of clinical investigation.

[15]  P. Leder,et al.  Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia , 1997, The Journal of experimental medicine.

[16]  E. Pearce,et al.  Schistosoma mansoni egg-induced early IL-4 production is dependent upon IL-5 and eosinophils , 1996, The Journal of experimental medicine.

[17]  A. Kapp,et al.  Human eotaxin represents a potent activator of the respiratory burst of human eosinophils , 1996, European journal of immunology.

[18]  H. Kita,et al.  Chemokines active on eosinophils: potential roles in allergic inflammation , 1996, The Journal of experimental medicine.

[19]  M. van de Rijn,et al.  Eotaxin Triggers Eosmophil-Selective Chemotaxis and Calcium Flux via a Distinct Receptor and Induces Pulmonary Eosinophilia in the Presence of Interleukin 5 in Mice , 1996, Molecular medicine.

[20]  D. Wong,et al.  Human eosinophils elaborate the lymphocyte chemoattractants. IL-16 (lymphocyte chemoattractant factor) and RANTES. , 1996, Journal of immunology.

[21]  R. Egan,et al.  Effects of interleukin 5-induced pulmonary eosinophilia on airway reactivity in the guinea pig. , 1996, The American journal of physiology.

[22]  P. Foster,et al.  Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model , 1996, The Journal of experimental medicine.

[23]  R. Locksley,et al.  Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity [published erratum appears in J Exp Med 1997 May 5;185(9):1715] , 1996, The Journal of experimental medicine.

[24]  N. Copeland,et al.  Mouse Eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response. , 1996, Immunity.

[25]  P. Hodgkin,et al.  IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. , 1996, Immunity.

[26]  T. Williams,et al.  Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo , 1995, The Journal of experimental medicine.

[27]  M C Swanson,et al.  Allergen-specific IgG1 and IgG3 through Fc gamma RII induce eosinophil degranulation. , 1995, The Journal of clinical investigation.

[28]  M. Seminario,et al.  The role of eosinophils in the pathogenesis of asthma. , 1994, Current opinion in immunology.

[29]  N. Barnes,et al.  Serum interleukin 5 concentrations in atopic and non-atopic patients with glucocorticoid-dependent chronic severe asthma. , 1994, Thorax.

[30]  J. Hsuan,et al.  Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation , 1994, The Journal of experimental medicine.

[31]  J. Tavernier,et al.  Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion , 1994, The Journal of experimental medicine.

[32]  M. Kohonen-Corish,et al.  Interleukin‐5 expressed by a recombinant virus vector enhances specific mucosal IgA responses in vivo , 1993, European journal of immunology.

[33]  D. Wong,et al.  Accessory cell function of human eosinophils. HLA-DR-dependent, MHC-restricted antigen-presentation and IL-1 alpha expression. , 1993, Journal of immunology.

[34]  G. Firestein,et al.  Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. , 1992, The Journal of clinical investigation.

[35]  F. Leyva-Cobián,et al.  Eosinophil as antigen‐presenting cell: activation of T cell clones and T cell hybridoma by eosinophils after antigen processing , 1992, European journal of immunology.

[36]  T. Fukuda,et al.  Airway hyperresponsiveness, increased intracellular spaces of bronchial epithelium, and increased infiltration of eosinophils and lymphocytes in bronchial mucosa in asthma. , 1992, The American review of respiratory disease.

[37]  C. Harley,et al.  Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1). , 1992, The Journal of clinical investigation.

[38]  S. Durham,et al.  Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. , 1992, The New England journal of medicine.

[39]  L. Koenderman,et al.  In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals. , 1992, Blood.

[40]  D. Wong,et al.  Eosinophils from patients with blood eosinophilia express transforming growth factor beta 1. , 1991, Blood.

[41]  S. Nourshargh,et al.  The accumulation of 111In-eosinophils induced by inflammatory mediators, in vivo. , 1991, Immunology.

[42]  F. Luscinskas,et al.  Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules , 1991, The Journal of experimental medicine.

[43]  A J Wardlaw,et al.  Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. , 1991, The Journal of clinical investigation.

[44]  G. Gleich,et al.  Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. , 1991, The Journal of clinical investigation.

[45]  E. Ingley,et al.  Production and purification of recombinant human interleukin-5 from yeast and baculovirus expression systems. , 1991, European journal of biochemistry.

[46]  H. Kita,et al.  Regulatory effect of cytokines on eosinophil degranulation. , 1990, Journal of immunology.

[47]  C. Sanderson,et al.  Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF. , 1989, Blood.

[48]  B. Coupar,et al.  A general method for the construction of recombinant vaccinia viruses expressing multiple foreign genes. , 1988, Gene.

[49]  N. Flavahan,et al.  The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity. , 1988, The Journal of allergy and clinical immunology.

[50]  T. Suda,et al.  Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor , 1988, The Journal of experimental medicine.

[51]  J. Gamble,et al.  Recombinant human interleukin 5 is a selective activator of human eosinophil function , 1988, The Journal of experimental medicine.

[52]  N. Flavahan,et al.  Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle. Role of the epithelium. , 1988, The American review of respiratory disease.

[53]  A. Wardlaw,et al.  Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. , 1988, The American review of respiratory disease.

[54]  H. Sluiter,et al.  Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. , 1985, The American review of respiratory disease.

[55]  D. Loegering,et al.  Cytotoxic properties of the eosinophil major basic protein. , 1979, Journal of immunology.

[56]  G. Discombe Criteria of eosinophilia. , 1946, Lancet.